{
    "$schema": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/QualificationPlan/v3.1/schemas/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Probenecid",
            "Path": "https://raw.githubusercontent.com/ErikssonJ/Probenecid-Model/refs/heads/main/Probenecid-Model.json"
        },
        {
            "Id": "Furosemide",
            "Path": "https://raw.githubusercontent.com/mgsc1020/Furosemide-Model/refs/heads/main/Furosemide-Model.json"
        },
        {
            "Id": "Probenecid-Furosemide-DDI",
            "Path": "https://raw.githubusercontent.com/mgsc1020/Probenecid-Furosemide-DDI/refs/heads/main/Probenecid-Furosemide-DDI.json",
            "BuildingBlocks": [
                {
                    "Type": "Compound",
                    "Name": "Probenecid",
                    "Project": "Probenecid"
                },
                {
                    "Type": "Formulation",
                    "Name": "tablet",
                    "Project": "Probenecid"
                },
                {
                    "Type": "Compound",
                    "Name": "Furosemide",
                    "Project": "Furosemide"
                }, 
                {
                    "Type": "Formulation",
                    "Name": "Solution",
                    "Project": "Furosemide"
                },
                {
                    "Type": "Formulation",
                    "Name": "Immediate release",
                    "Project": "Furosemide"
                }

            ]
        }
    ],
    "ObservedDataSets": [
        {
            "Id": "DDI Ratios",
            "Path": "../../DDI.csv",
            "Type": "DDIRatio"
        }
    ],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [],
        "GOFMergedPlots": [],
        "ComparisonTimeProfilePlots": [
            {
                "SectionReference": "Probenecid-Furosemide-DDI-timeprofile",
                "Title": "Homeida 1977 (40mg IV)",
                "SimulationDuration": 80,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "iv, 40  mg (bolus)_Homeida 1977_1001",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Homeida 1977 - Furosemide control_Furosemide_40_iv_1001_Plasma",
                        "StartTime": 74,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Probenecid)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "iv, 40  mg (bolus)_Homeida 1977_2001_with probenecid",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Homeida 1977 - with probenecid_Furosemide_40_iv_2001_Plasma",
                        "StartTime": 74,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with Probenecid)",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionReference": "Probenecid-Furosemide-DDI-timeprofile",
                "Title": "Smith 1980 (40 mg IV)",
                "SimulationDuration": 30,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "iv, 40 mg (3 min)_Smith 1980_1002+3002",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Smith 1980 - Furosemide control_Furosemide_40_iv_1002_Plasma",
                        "StartTime": 13,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Probenecid)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "iv, 40 mg (3 min)_Smith 1980_2002+4002_with probenecid",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Smith 1980 - with probenecid_Furosemide_40_iv_2002_Plasma",
                        "StartTime": 13,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with Probenecid)",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionReference": "Probenecid-Furosemide-DDI-timeprofile",
                "Title": "Wiebe 2020 (0.1mg PO)",
                "SimulationDuration": 50,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "po, 1  mg (sol)_Wiebe 2020_1005+3005_Mean",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Wiebe 2020 - Furosemide control_Furosemide_1_po_1005_Plasma",
                        "StartTime": 13,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Probenecid)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "po, 1  mg (sol)_Wiebe 2020_2005+4005_Mean_with probenecid",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Wiebe 2020 - with probenecid_Furosemide_1_po_2005_Plasma",
                        "StartTime": 13,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with Probenecid)",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionReference": "Probenecid-Furosemide-DDI-timeprofile",
                "Title": "Wiebe 2020 (40mg PO)",
                "SimulationDuration": 50,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "po, 40  mg (sol)_Wiebe 2020_1006+3006_Mean",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Wiebe 2020 - Furosemide control_Furosemide_40_po_1006_Plasma",
                        "StartTime": 10,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Probenecid)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "po, 40  mg (sol)_Wiebe 2020_2006+4006_Mean_with probenecid",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Wiebe 2020 - with probenecid_Furosemide_40_po_2006_Plasma",
                        "StartTime": 10,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with Probenecid)",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionReference": "Probenecid-Furosemide-DDI-timeprofile",
                "Title": "Shen 2019 (40mg PO)",
                "SimulationDuration": 30,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "po, 40 mg (tab)_Shen 2019_1003",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Shen 2019 - Furosemide control_Furosemide_40_po_1003_Plasma",
                        "StartTime": 1,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Probenecid)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "po, 40 mg (tab)_Shen 2019_2003_with probenecid",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Shen 2019 - with probenecid_Furosemide_40_po_2003_Plasma",
                        "StartTime": 1,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with Probenecid)",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionReference": "Probenecid-Furosemide-DDI-timeprofile",
                "Title": "Vree 1995 (80mg PO)",
                "SimulationDuration": 20,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "po, 80 mg (tab)_Vree 1995_1004+3004",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Vree 1995 - Furosemide control_Furosemide_80_po_1004_Plasma",
                        "StartTime": 1,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Probenecid)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Probenecid-Furosemide-DDI",
                        "Simulation": "po, 80 mg (tab)_Vree 1995_2004+4004_with probenecid",
                        "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Vree 1995 - with probenecid_Furosemide_80_po_2004_Plasma",
                        "StartTime": 1,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment (with Probenecid)",
                        "Symbol": "Square"
                    }
                ]
            }
        ],
            "DDIRatioPlots": [
            {
                "SectionReference": "qualification-of-use-case-oat-ddi",
                "Title": "Probenecid-Furosemide DDI",
                "PKParameters": [
                    "AUC_tEnd",
                    "C_max"
                ],
                "PlotTypes": [
                    "predictedVsObserved",
                    "residualsVsObserved"
                ],
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure",
                    "Table"
                ],
                "Subunits": [
                    "Mechanism",
                    "Perpetrator",
                    "Victim"
                ],
                "Groups": [
                    {
                        "Caption": "Probenecid + Furosemide (IV)",
                        "Color": "#FF0000",
                        "Symbol": "Square",
                        "DDIRatios": [
                            {
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 17000,
                                "SimulationControl": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "iv, 40  mg (bolus)_Homeida 1977_1001",
                                    "StartTime": 72,
                                    "EndTime": 77,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "iv, 40  mg (bolus)_Homeida 1977_2001_with probenecid",
                                    "StartTime": 72,
                                    "EndTime": 77,
                                    "TimeUnit": "h"
                                }
                            },
                            {
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 17001,
                                "SimulationControl": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "iv, 40 mg (3 min)_Smith 1980_1002+3002",
                                    "StartTime": 13,
                                    "EndTime": 18,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "iv, 40 mg (3 min)_Smith 1980_2002+4002_with probenecid",
                                    "StartTime": 13,
                                    "EndTime": 18,
                                    "TimeUnit": "h"
                                }
                            }                            
                        ]
                    },
                    {
                        "Caption": "Probenecid + Furosemide (PO)",
                        "Color": "#FF0000",
                        "Symbol": "Circle",
                        "DDIRatios": [
                            {
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 17002,
                                "SimulationControl": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "po, 1  mg (sol)_Wiebe 2020_1005+3005_Mean",
                                    "StartTime": 13,
                                    "EndTime": 37,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "po, 1  mg (sol)_Wiebe 2020_2005+4005_Mean_with probenecid",
                                    "StartTime": 13,
                                    "EndTime": 37,
                                    "TimeUnit": "h"
                                }
                            },
                            {
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 17003,
                                "SimulationControl": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "po, 40  mg (sol)_Wiebe 2020_1006+3006_Mean",
                                    "StartTime": 13,
                                    "EndTime": 37,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "po, 40  mg (sol)_Wiebe 2020_2006+4006_Mean_with probenecid",
                                    "StartTime": 13,
                                    "EndTime": 37,
                                    "TimeUnit": "h"
                                }
                            },
                            {
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 17004,
                                "SimulationControl": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "po, 40 mg (tab)_Shen 2019_1003",
                                    "StartTime": 0,
                                    "EndTime": 24,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "po, 40 mg (tab)_Shen 2019_2003_with probenecid",
                                    "StartTime": 0,
                                    "EndTime": 24,
                                    "TimeUnit": "h"
                                }
                            },
                            {
                                "Output": "Organism|PeripheralVenousBlood|Furosemide|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DDI Ratios",
                                "ObservedDataRecordId": 17005,
                                "SimulationControl": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "po, 80 mg (tab)_Vree 1995_1004+3004",
                                    "StartTime": 1,
                                    "EndTime": 12,
                                    "TimeUnit": "h"
                                },
                                "SimulationDDI": {
                                    "Project": "Probenecid-Furosemide-DDI",
                                    "Simulation": "po, 80 mg (tab)_Vree 1995_2004+4004_with probenecid",
                                    "StartTime": 1,
                                    "EndTime": 12,
                                    "TimeUnit": "h"
                                }
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "Inputs": [],
    "Sections": [
        {
            "Reference": "introduction",
            "Title": "Introduction",
            "Sections": [
                {
                    "Reference": "objective",
                    "Title": "Objective",
                    "Content": "Content/Qualification_DDI_objective.md"
                },
                {
                    "Reference": "oat-ddi-network",
                    "Title": "OAT DDI network",
                    "Content": "Content/Qualification_description.md",
                    "Sections": [
                        {
                            "Reference": "Probenecid-Furosemide-DDI",
                            "Title": "Probenecid-Furosemide-DDI",
                            "Content": "Content/Probenecid-Furosemide-DDI.md"
                        }
                    ]
                }
            ]
        },
        {
            "Reference": "qualification-of-use-case-oat-ddi",
            "Title": "Qualification of Use Case Probenecid-Furosemide DDI",
            "Content": "Content/Intro_evaluation_DDI_network.md"
        },
        {
            "Reference": "concentration-time-profiles",
            "Title": "Concentration-Time Profiles",
            "Content": "Content/Intro_evaluation_CTprofiles.md",
            "Sections": [
                {
                    "Reference": "Probenecid-Furosemide-DDI-timeprofile",
                    "Title": "Probenecid-Furosemide DDI"
                }
            ]
        },
        {
            "Reference": "references",
            "Title": "References",
            "Content": "Content/References.md"
        },
        {
            "Reference": "appendix",
            "Title": "Appendix",
            "Sections": [
                {
                    "Reference": "osp-introduction",
                    "Title": "Open Systems Pharmacology Suite (OSPS) Introduction",
                     "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.3/OSPS_Introduction.md"
                },
                {
                    "Reference": "mathematical-implementation-of-ddi",
                    "Title": "Mathematical Implementation of Drug-Drug Interactions",
                     "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.3/Mathematical_Implementation_of_DDI.md"
                },
                {
                    "Reference": "automatic-requalification-workflow",
                    "Title": "Automatic (re)-qualification workflow",
                    "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.3/Qualification_Workflow.md"
                }
            ]
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
          }
    ]
}